This stimulation takes place via an NFκB-dependent mechanism that drives tissue regeneration and angiogenesis, reduces anti-tumour immunity and allows the tumour to escape from immune surveillance in a 3-D culture system [119,120,121,122]. The gene discussed is NFKB1; the disease is neoplasm.